IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q1 2020 Holdings

Filed 2020-05-15 | 17 holdings | $423.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Crescent Cap BDC Inc(CCAP)COM225655109$332.0K34,40578.5%
Molecular Templates IncCOM608550109$28.0K2,107,9916.6%
Kala Pharmaceuticals IncCOM483119103$16.1K1,836,3133.8%
Satsuma Pharmaceuticals IncCOM80405P107$13.0K606,3203.1%
Strongbridge Biopharma PLCSHS USDG85347105$12.5K6,612,0653.0%
Sierra Oncology IncCOM NEW82640U404$6.3K643,9591.5%
Scynexis IncCOM811292101$6.2K7,936,1111.5%
Sunesis Pharmaceuticals IncCOM PAR867328700$3.4K8,134,9260.8%
Garrison Cap Inc(GARSUSD)COM366554103$2.0K1,164,0610.5%
MEI Pharma IncCOM NEW55279B202$1.4K885,5600.3%
CTI Biopharma Corp(CTIC1USD)COM NEW12648L601$567616,6950.1%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$55581,6170.1%
FS KKR Capital Corp(FSICUSD)COM302635107$511170,3320.1%
Kura Oncology Inc(KURA)COM50127T109$22222,3020.1%
Calumet Specialty Prods PtnrUT LTD PARTNER131476103$138131,2040.0%
Addex Therapeutics LTD(ADXNUSD)SPONSORED ADS00654J107$11517,4180.0%
Glycomimetics Inc(GLYCEUR)COM38000Q102$3415,1030.0%